| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/01/2009 | EP2041116A1 Phenyl substituted heteroaryl-derivatives and use thereof as anti-tumor agents |
| 04/01/2009 | EP2041115A1 New pyridine analogues |
| 04/01/2009 | EP2041114A2 Inhibitors of advanced glycation end products |
| 04/01/2009 | EP2041113A1 Novel pyridazine derivatives |
| 04/01/2009 | EP2041112A1 New pyridine analogues |
| 04/01/2009 | EP2041111A1 New pyridine analogues |
| 04/01/2009 | EP2041094A1 Biarylcarboxyarylamides as vanilloid-1 receptor modulators |
| 04/01/2009 | EP2041086A1 Indole compounds |
| 04/01/2009 | EP2041085A1 Pyrrole derivatives and their methods of use |
| 04/01/2009 | EP2041071A2 Biaryl compositions and methods for modulating a kinase cascade |
| 04/01/2009 | EP2041069A1 Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| 04/01/2009 | EP2041067A2 Cxer4 antagonists including diazine and triazine structures for the treatment of medical disorders |
| 04/01/2009 | EP2040710A2 Novel polymorph of esomeprazole potassium and process for its preparation |
| 04/01/2009 | EP2040698A2 Oxime compounds and the use thereof |
| 04/01/2009 | EP1773770B1 Indole-2-carboxamidine derivatives as nmda receptor antagonists |
| 04/01/2009 | EP1673348B1 Benzoimidazole compounds |
| 04/01/2009 | EP1653961A4 Inhibitors of akt activity |
| 04/01/2009 | EP1620429B1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 04/01/2009 | EP1513530A4 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 04/01/2009 | EP1506175B1 N-substituted tricyclic 3-aminopyrazoles as pdgf receptor inhibitors |
| 04/01/2009 | EP1082308B1 Heterocyclically substituted amides used as calpain inhibitors |
| 04/01/2009 | CN101400677A Compounds |
| 04/01/2009 | CN101400671A Substituted prolinamides, their preparation and their use as pharmaceuticals |
| 04/01/2009 | CN101400670A Novel pyridine derivative having anti-helicobacter pylori activity |
| 04/01/2009 | CN101400669A Benzimidazole derivatives |
| 04/01/2009 | CN101400668A 2-(cyclic amino)-pyrimidone derivatives as TPK1 inhibitors |
| 04/01/2009 | CN101400656A Piperazine derivatives as farnesyl protein transferase inhibitors |
| 04/01/2009 | CN101400654A 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors |
| 04/01/2009 | CN101400653A 11-beta HSD1 inhibitors |
| 04/01/2009 | CN101400651A Diaryl piperidines as CB1 modulators |
| 04/01/2009 | CN101397293A Green nitration method based on ion liquid catalysis |
| 04/01/2009 | CN100473651C Pyrazolyl-substituted heterocycles and use thereof as phytosanitary products |
| 04/01/2009 | CN100473647C Pyridazinones and triazinones and medicinal use thereof |
| 04/01/2009 | CN100473381C Use of epothilones in the treatment of brain diseases associated with proliferative processes |
| 03/31/2009 | US7511159 Azetidine ring compounds and drugs comprising the same |
| 03/31/2009 | US7511146 2-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 03/31/2009 | US7511145 Bicyclic heteroaryl derivatives |
| 03/31/2009 | US7511144 Reverse hydroxamic acid derivatives |
| 03/31/2009 | US7511136 Anticancer agents; antiproliferative agents; Alzheimer's disease; viricides; autoimmune diseases; central nervous system disorders |
| 03/31/2009 | US7511072 7-amido-isoindolyl compounds and methods of its use |
| 03/31/2009 | US7511069 Indazole compounds as β3 andrenoceptor agonist |
| 03/31/2009 | US7511066 Antithrombotic aromatic ethers |
| 03/31/2009 | US7511064 Treating conditions alleviated by 5-HT2B antagonists such as migraine, gastrointestinal disorders; restenosis, asthma, obstructive airway disease, bronchial pulmonary dysplasia, prostatic hyperplasia and priapism; hypotensive agents |
| 03/31/2009 | US7511062 Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors |
| 03/31/2009 | US7511061 Triazoles as farnesyl transferase inhibitors |
| 03/31/2009 | US7511056 TGF-β inhibitors |
| 03/31/2009 | US7511052 N-[2-diethylamino-5-{N-ethyl-N-(trifluoroacetyl)amino}pyrimidin-4-yl]-L-4'-{(pyrrolidin-1-yl)carbonyloxy}phenylalanine; antiinflammatory agent; asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation |
| 03/31/2009 | US7511047 Kinase inhibitors |
| 03/31/2009 | US7511044 Vanilloid receptor ligands and their use in treatments |
| 03/31/2009 | US7511042 1-[5-(5-tert-Butyl-2-methoxy-3-methylsulfamoyl-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazole-4-carboxylic acid (2,2-dimethyl-propyl)-amide; small molecule cytokine inhibitor; optimized efficacy, pharmacokinetic; antiinflammatory agent, osteoarthritis, asthma, gastrointestinal, respiratory disorder |
| 03/31/2009 | US7511041 Fused azole-pyrimidine derivatives |
| 03/31/2009 | US7511038 Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors |
| 03/31/2009 | US7511021 2-{3-[2-(2,3-Dihydro-benzofuran-5-yl)-ethyl]-6-methyl-1H-indazol-4-yloxy} beta-D-glucopyranoside; sodium glucose transporter inhibitor; antidiabetic agent; Syndrome X, obesity, nephropathy, neuropathy, retinopathy, atherosclerosis, hypertension, ischemia, stroke, heart disease , and cataracts |
| 03/31/2009 | CA2448602C Pyrimidine, triazine and pyrazine derivatives as glutamate receptors |
| 03/31/2009 | CA2441313C New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 03/26/2009 | WO2009039140A1 Pyridopyrimidine derivatives as pi3 kinase inhibitors |
| 03/26/2009 | WO2009039135A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors |
| 03/26/2009 | WO2009039134A1 Anti-infective pyrimidines and uses thereof |
| 03/26/2009 | WO2009039127A1 Uracil or thymine derivative for treating hepatitis c |
| 03/26/2009 | WO2009038974A1 Compounds and compositions as modulators of gpr119 activity |
| 03/26/2009 | WO2009038847A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
| 03/26/2009 | WO2009038157A1 2,3-dihydroiminoisoindole derivative |
| 03/26/2009 | WO2009038057A1 Nitrogenated fused-ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 03/26/2009 | WO2009037308A1 Inhibitors of the interaction between mdm2 and p53 |
| 03/26/2009 | WO2009037302A1 5-substituted-1, 4-benz0diazepines as phosphodiesterase inhibitors |
| 03/26/2009 | WO2009037296A1 Compounds which have activity at m1 receptor and their uses in medicine |
| 03/26/2009 | WO2009037294A1 Compounds which have activity at m1 receptor and their uses in medicine |
| 03/26/2009 | WO2009037277A1 Compounds useful as ligands and particularly as organic chromophores for complexing lanthanides and applications thereof |
| 03/26/2009 | WO2009037247A1 Pyrazine derivatives and their use as potassium channel modulators |
| 03/26/2009 | WO2009037244A2 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists |
| 03/26/2009 | WO2009037222A1 Diacylglycerol acyltransferase inhibitors |
| 03/26/2009 | WO2009036996A2 Small molecule bradykinin b1 receptor antagonists |
| 03/26/2009 | WO2009036938A1 Substituted nicotinamide compounds and the use thereof in pharmaceutical products |
| 03/26/2009 | WO2009036909A1 Halosubstituted aryloxyalkylimidazolines for use as pesticides |
| 03/26/2009 | WO2009036908A1 Halosubstituted aryloxyalkylimidazolines for use as pesticides |
| 03/26/2009 | WO2009036766A1 Cyanoisoquinoline |
| 03/26/2009 | WO2009036753A2 Novel pharmaceuticals, method for the production thereof and use thereof in medical therapy |
| 03/26/2009 | WO2009017624A3 Compositions with enhanced bioavailability and fast acting inhibitor of gastric acid secretion |
| 03/26/2009 | WO2009016460A3 Pyrazole compounds and their use as raf inhibitors |
| 03/26/2009 | WO2009016253A3 Cyanomethyl substituted n-acyl tryptamines |
| 03/26/2009 | WO2009010129A8 Bispidon ligands and the metal complexes thereof |
| 03/26/2009 | WO2009007753A3 4- (3-aminopyrazole) -pyrimidine derivativee and their use as tyrosine kinase inhibitors for the treatment of cancer |
| 03/26/2009 | WO2009006389A8 Pyrimidine derivatives useful as raf kinase inhibitors |
| 03/26/2009 | WO2008139288A3 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials |
| 03/26/2009 | WO2008042422A3 Bicyclic and tricyclic derivatives as thrombin receptor antagonists |
| 03/26/2009 | WO2008032204A8 Substituted pyridylmethyl bicyclocarboxyamide compounds |
| 03/26/2009 | US20090082572 Process for amorphous esomeprazole |
| 03/26/2009 | US20090082570 Method of manufacturing bipyridinium compound and synthetic intermediate of the same, method of manufacturing dye compound, and novel bipyridinium compound and novel dye compound comprising the same |
| 03/26/2009 | US20090082567 2,4-pyrimidinediamine compounds and their uses |
| 03/26/2009 | US20090082404 Benzimidazoles |
| 03/26/2009 | US20090082403 Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same |
| 03/26/2009 | US20090082399 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 03/26/2009 | US20090082397 anticholinergic agents such as biphenyl-2-ylcarbamic Acid 1-{2-[5-(4-Carbamoylpiperidin-1-yl)pentylcarbamoyl]ethyl}piperidin-4-yl ester, used for the treatment of respiratory system disorders such as chronic obstructive pulmonary disease and asthma; side effect reduction |
| 03/26/2009 | US20090082396 5-aryl-4,5-dihydro-(1h)-pyrazolines as cannabinoid cb1 receptor agonists |
| 03/26/2009 | US20090082390 Piperidine compounds for use as orexin receptor antagonist |
| 03/26/2009 | US20090082389 Pesticidal substituted piperidines |
| 03/26/2009 | US20090082379 Novel Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors |
| 03/26/2009 | US20090082378 Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the b2 adrenergic receptor |
| 03/26/2009 | US20090082375 Solid forms comprising 3-(2,5-dimethyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, compositions comprising the same, and methods of using the same |
| 03/26/2009 | US20090082367 Triazole derivative or a salt thereof |